Other
Dummy Placebo
Dummy Placebo is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
3
75%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
Enrolling by invitation1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (75.0%)
N/A1 (25.0%)
Trials by Status
enrolling_by_invitation125%
completed250%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
enrolling_by_invitationnot_applicable
Efficacy of Counselling for the Prevention of Hypertension (ECoPH)
NCT07012096
completedphase_4
Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease
NCT02194686
unknownphase_4
Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease
NCT02174939
completedphase_4
Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)
NCT01952756
Clinical Trials (4)
Showing 4 of 4 trials
NCT07012096Not Applicable
Efficacy of Counselling for the Prevention of Hypertension (ECoPH)
NCT02194686Phase 4
Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease
NCT02174939Phase 4
Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease
NCT01952756Phase 4
Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4